Regeneron Pharmaceuticals Inc

REGN 
(NASDAQ) 
 
$ 390.28
Updated 01:00:00
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 954,023
High $ 0
Low $ 0
Open $ 389.73
ISIN
Prev close $ 387.25
# of shares 106.14M
Market cap 41,426M USD
Intraday

Market closed
Regeneron Pharmaceuticals Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  390.28 -0.5% Stock price decreasing 2.7% Stock price increasing 17.6% Stock price increasing 19.1% Stock price increasing -9.8% Stock price decreasing
Powered by TradingView

News about Regeneron Pharmaceuticals Inc

  • English
  • Regulatory news

Company profile

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 September 2018 16:51:38
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB7 - 2018-09-22 17:51:38 - 2018-09-22 16:51:38 - 1000 - Website: OKAY